Although the Federal Trade Commission won its effort to quash a lawsuit over its probe of LabMD, the now-defunct medical laboratory is still trying to sue three agency employees.
Unexpected, surreptitious fees in retail transactions — additions like “convenience fees” and “resort fees” — have proliferated wildly over the past 30 years. When they aren’t clearly disclosed at the start of a transaction, their omission can deceive consumers and distort the purchase decision....
Current Issue: 949
The Federal Trade Commission’s sweeping hearings on 21st century issues in antitrust and consumer protection continue to win plaudits from lawyers and academics, but some critics think the agency...
Commissioners at the Federal Trade Commission often vote in step with members of their own party, especially when they’re in the minority.
Insights into Makan Delrahim’s oversight of the government’s lawsuit to block AT&T’s acquisition of Time Warner — including his interpretation of key facts and critical conversations with...
Rohit Chopra has staked out an aggressive position on the five-member Federal Trade Commission, questioning a system where first-time violators of the FTC Act’s prohibitions against deceptive...
When the Justice Department approved the merger of CVS Health and Aetna — subject to a divestiture — critics blasted the government’s action as paving the way for higher costs to consumers.
Antitrust enforcers will have another weapon in their arsenal when going after drugmakers for anticompetitive practices because of a measure signed by President Donald Trump earlier this month.